Cross-resistance Between Rifampicin and Rifabutin and Its Relationship with rpoB Gene Mutations in Clinically Isolated MDR-TB Strains.
Byoung Ju Kim, Seung Hwan Oh, Eun Jin Cho, Seung Kyu Park
Tuberc Respir Dis. 2006;60(2):171-179.   Published online 2006 Feb 1     DOI: https://doi.org/10.4046/trd.2006.60.2.171
Citations to this article as recorded by Crossref logo
Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea
Se-Mi Jeon, Sanghee Park, Na-Ra Lim, Noori Lee, Jihee Jung, Nackmoon Sung, Seonghan Kim
Antibiotics.2023; 12(8): 1324.     CrossRef
Current Status of the Third-LineHelicobacter pyloriEradication
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee, Gwang Ho Baik
Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
Diagnosis and Treatment of Multidrug-Resistant Tuberculosis
Tae Sun Shim
Korean Journal of Medicine.2015; 88(5): 509.     CrossRef
The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis
Kyung-Wook Jo, Wonjun Ji, Yoonki Hong, Sang-Do Lee, Woo Sung Kim, Dong Soon Kim, Tae Sun Shim
Respiratory Medicine.2013; 107(2): 292.     CrossRef
Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
Tae Sun Shim, Kyung-Wook Jo
Infection & Chemotherapy.2013; 45(4): 367.     CrossRef
Evaluation of the AdvanSure MDR-TB GenoBlot Assay for Detection of Rifampin and Isoniazid ResistantMycobacterium tuberculosisComplex in Respiratory Specimens
Jayoung Kim, Yeon-Joon Park, Nam Yong Lee, Chulhun L. Chang, Miae Lee, Jong Hee Shin
Korean Journal of Clinical Microbiology.2012; 15(4): 117.     CrossRef